| PMNLs/HPF cervix | FVU PMNLs/HPF | Cervix PMNLs/HPF | Total (FVU or cervix) PMNLs/HPF | |||
| <30 | >30 | <30 | >30 | <30 | >30 | |
| M genitalium positive (%) | 80 (45) | 98 (55) | 124 (49) | 128 (51) | 141 (48) | 152 (52) |
| OR | 1.5 | 1.3 | 1.3 | |||
| 95% CI | 1.1 to 2.0 | 1.0 to 1.6 | 1.0 to 1.7 | |||
| C trachomatis positive (%) | 200 (32) | 425 (68) | 205 (32) | 439 (68) | 238 (33) | 474 (67) |
| OR | 2.6 | 2.6 | 2.4 | |||
| 95% CI | 2.2 to 3.1 | 2.2 to 3.1 | 2.1 to 2.9 | |||
| M genitalium and C trachomatis negative (%) | 3554 (55) | 2902 (45) | 3519 (55) | 2879 (45) | 3531 (55) | 2894 (45) |
Association was determined by comparing microscopic examination of polymorphic mononuclear leucocytes per high-powered field (PMNLs/HPF) in cervical smears in turn with microorganisms found in the first void urine (FVU) (M genitalium, n = 178; C trachomatis, n = 625; no organism, n = 6456), microorganisms found in the cervix (M genitalium, n = 252; C trachomatis, n = 644; no organism, n = 6398) or microorganisms found in either the FVU or cervical swab specimen (M genitalium, n = 293; C trachomatis, n = 712; no organism, n = 6425). Patients positive for both M genitalium and C trachomatis (n = 42) have been excluded from the calculation.